European Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher in Monday Trading
Asahi Kasei Launches Tender Offer for Calliditas Therapeutics
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
Express News | Reported Thursday, Calliditas Therapeutics And Viatris Initiate Phase III Clinical Trial Of Nefecon For IgA Nephropathy In Japan
Calliditas Partner Starts Late-stage Trial for Kidney Disease Treatment
Launch of Phase 3 Clinical Trial With Nefecon in Japan
Calliditas Therapeutics Receives Patent For NOX Inhibitors For Treatment Of Cancer
Calliditas Provides Setanaxib Patent Update
Bulletin From the Annual General Meeting of Calliditas Therapeutics AB (Publ)
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
Tech Firms Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Calliditas Therapeutics AB Buyout
Critical Insights From Calliditas Therapeutics Analyst Ratings: What You Need To Know
Calliditas Therapeutics Cut to Neutral From Buy by Citigroup
Calliditas Therapeutics Price Target Announced at $39.00/Share by Citigroup
Citi Downgrades Calliditas to Neutral, Cites Takeover Offer
Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39
Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment